Can a massive Real-World registry make vascular access safer?
NCT ID NCT06604039
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This study is a large registry that will follow about 2,500 people who receive a Teleflex vascular access device—such as a central venous catheter, dialysis catheter, or peripheral IV—during their medical care. The goal is to collect real-world data on how well these devices work and how safe they are in everyday hospital settings. Researchers will track successful device use without complications and any device-related adverse events. The findings could help improve the safety and effectiveness of these common medical tools.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Teleflex vascular access devices (central venous catheters, dialysis catheters, midline IV catheters, peripheral IV catheters, arterial catheters, and catheter navigation/tip confirmation devices)
- What this could lead to
- If successful, this registry could provide real-world evidence on the safety and performance of these devices, potentially guiding better clinical practices and device improvements.
- What could go wrong
- As an observational registry, it cannot prove cause and effect, and results may be influenced by variations in real-world use and patient populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR ACCESS DEVICE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huntsville Hospital
RECRUITINGHuntsville, Alabama, 35801, United States
-
Loma Linda University Health
RECRUITINGLoma Linda, California, 92354, United States
-
Tufts Medical Center
RECRUITINGBoston, Massachusetts, 02111, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.